GS-012 - Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients with HCV Genotype 5 or 6 Infection: The ENDURANCE-5,6 Study

Autor: Asselah, T., Tran, T., Alves, K., Nguyen, T., Wong, F., Mahomed, A., Lim, S.G., Lee, S., Abergel, A., Sasadeusz, J., Krishnan, P., Zhang, Z., Pocalla, A., Trinh, R., Gane, E.
Zdroj: In Journal of Hepatology April 2018 68 Supplement 1:S39-S39
Databáze: ScienceDirect
Externí odkaz: